By Robert H. Frank for the New York Times
Republicans are in a bind. They’ve been promising to repeal Obamacare for seven years, and now, having won control of the White House and Congress, they must try to deliver. But while their bitter denunciations of the Affordable Care Act may have depressed its approval numbers, they haven’t made replacing it any easier.
On the contrary, the repeal-and-replace bill designed by House Speaker Paul D. Ryan has drawn withering criticism from the left and the right. Liberals condemn its use of reductions in health coverage for the poor to pay for large tax cuts for the wealthy, while conservatives bemoan its retention of many subsidies adopted under Obamacare.
In the end, the repeal effort’s biggest hurdle may be loss aversion, one of the most robust findings in behavioral science. As numerous studies have shown, the pain of losing something you already have is much greater than the pleasure of having gained it in the first place. And the nonpartisan Congressional Budget Office estimates that Mr. Ryan’s American Health Care Act (A.H.C.A.) would cause more than 14 million people to lose coverage in the first year alone, with total losses rising to 24 million over the next decade. Many Republicans in Congress appear nervous about the political firestorm already provoked by the mere prospect of such losses.
Loss aversion actually threatens the repeal effort on two fronts: voters’ fear of losing their coverage, and lawmakers’ fear of losing their seats. Like the first fear, the second appears well grounded. Republican voters won’t be the only ones losing coverage, of course, but early studies suggest that losses may be concentrated among people who voted for President Trump. The Congressional Budget Office has estimated, for example, that the A.H.C.A. would cause premiums to rise more than sevenfold in 2026 for 64-year-olds making $26,500.
If the repeal effort stalls, attention will shift to what comes next. In an earlier column, I suggested that Mr. Trump has the political leverage, which President Obama did not, to jettison the traditional Republican approach in favor of a form of the single-payer health care that most other countries use. According to Physicians for a National Health Program, an advocacy group, “Single-payer national health insurance, also known as ‘Medicare for all,’ is a system in which a single public or quasi-public agency organizes health care financing, but the delivery of care remains largely in private hands.” Christopher Ruddy, a friend and adviser of the president, recently urged him to consider this option.
Many Republicans who want to diminish government’s role in health care view the single-payer approach with disdain. But Mr. Trump often seems to take pleasure in being unpredictable, and since he will offend people no matter which way he turns, he may want to consider why liberals and conservatives in many other countries have embraced the single-payer approach.
Part of the appeal of Medicare for all is that single-payer systems reduce financial incentives that generate waste and abuse. Mr. Ryan says that by relegating health care to private insurers, competition will lead to lower prices and higher quality. Economic theory tells us that this is a reasonable expectation when certain conditions are met. A crucial one is that buyers must be able to compare the quality of offerings of different sellers. In practice, however, people have little knowledge of the treatment options for the various maladies they might suffer, and policy language describing insurance coverage is notoriously complex and technical. Consumers simply cannot make informed quality comparisons in this industry.
In contrast, they can easily compare the prices charged by competing insurance companies. This asymmetry induces companies to compete for customers by highlighting the lower prices they’re able to offer if they cut costs by degrading the quality of their offerings. For example, it’s common for insurance companies to deny payment for procedures that their policies seem to cover. If policy holders complain loudly enough, they may eventually get reimbursed, but the money companies save by not paying others confers a decisive competitive advantage over rivals that don’t employ this tactic. Such haggling is uncommon under single-payer systems like Medicare (though it is sometimes employed by private insurers that supplement Medicare).
Consider, too, the mutually offsetting expenditures on competitive advertising and other promotional efforts of private insurers, which can exceed 15 percent of total revenue. Single-payer plans like Medicare spend nothing on competitive advertising (although here, also, we see such expenditures by supplemental insurers).
According to the Kaiser Family Foundation, administrative costs in Medicare are only about 2 percent of total operating expenditures, less than one-sixth of the rate estimated for the private insurance industry. This difference does not mean that private insurers are evil. It’s a simple consequence of a difference in the relevant economic incentives.
But advertising expenses and administrative costs are not the most important reason the United States spends so much more. The main difference is that prices for medical services are so much lower in other countries. In France, for example, a magnetic resonance imaging exam costs $363, on average, compared with $1,121 in the United States; an appendectomy is $4,463 in France, versus $13,851 in America. These differences stem largely from the fact that single payers — which is to say, governments — are typically able to negotiate more favorable terms with service providers.
In short, Medicare for all could deliver quality care at much lower cost than private insurers do now. People would of course be free to supplement their public coverage with private insurance, as they now do in most other countries with single-payer systems, and as many older Americans do with Medicare.
As a candidate, Mr. Trump repeatedly promised that everyone in the country would be covered at reasonable cost under an amazing new health plan. But it’s now clear that the A.H.C.A. cannot deliver on that promise. The president, who has not always had a close relationship with Mr. Ryan, might consider breaking with him and working across party lines to develop support for universal access to Medicare.
Then again, he might fear that abandoning his public pledge to support Mr. Ryan’s bill would be seen as a sign of weakness or defeat. But the research findings on loss aversion make one thing clear: Any setback from abandoning the bill will pale in comparison to the outrage that will come if the A.H.C.A. actually becomes law.
